Aug 174 minBoehringer Ingelheim Supports BioLabs First EU Location BioLabs Heidelberg with Founding Sponsorship
Jul 302 minApogenix to Start European Clinical Phase II Trial with Asunercept in COVID-19 PatientsHeidelberg, Germany, July 28, 2020–Apogenix, a biopharmaceutical company developing next generation immunotherapeutics, announ...
Jul 303 minCENTOGENE and Molecular Health Announce an Exclusive Collaboration With the Aim to Transform the Development of Orphan Drugs The combination of real-life data sets in rare diseases with innovative big da...
Jul 302 minIntravacc and Celonic to Develop and Produce a Novel COVID-19 VaccineCombining Intravacc’s OMV-delivery platform with Covid-19 Spike proteins Preclinical studies to start shortly for candidate selection and...
Jul 221 minHeidelberg Pharma: Main Shareholder dievini Commits to Further Financing for Expansion of PipelineLadenburg, Germany, 21 July 2020 - Heidelberg Pharma AG today announced that it has secured a financing commitment from its main sharehol...
